How to Help a Teenager Quit Vaping

Why is vaping so hard to quit — especially for teenagers?

Pod-style e-cigarettes deliver nicotine rapidly and in high concentrations. Research comparing urine cotinine levels found that adolescent pod users had higher nicotine exposure than conventional cigarette smokers of the same age, and were far more likely to identify as daily users (63% vs. 11% for non-pod e-cigarette users) 1Ref 1Boykan R, Goniewicz ML, Messina CR (2019).Evidence of Nicotine Dependence in Adolescents Who Use Juul and Similar Pod Devices.Pod-device users show elevated cotinine, higher daily-use rates, and more dependence symptoms than non-pod e-cigarette users in adolescents. The nicotine delivery profile of a 5% JUUL pod closely tracks that of combustible cigarettes in both peak concentration and time-to-peak 1Ref 1Boykan R, Goniewicz ML, Messina CR (2019).Evidence of Nicotine Dependence in Adolescents Who Use Juul and Similar Pod Devices.Pod-device users show elevated cotinine, higher daily-use rates, and more dependence symptoms than non-pod e-cigarette users in adolescents.

Nicotine is particularly harmful to the adolescent brain, which continues developing until the mid-twenties. Exposure during this window disrupts the normal maturation of neuronal nicotinic acetylcholine receptors and alters reward-related neurotransmitter release — changes that accelerate dependence and can increase impulsivity 2Ref 2McKelvey K, Baiocchi M, Halpern-Felsher B (2021).Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy.Adolescent brain vulnerability to nicotine — disrupted receptor development, reward pathway alteration, increased dependence risk. This is not a character flaw; it is a biological vulnerability that makes the conversation about quitting a medical one, not a moral one.

That said, the picture has been shifting. The 2024 National Youth Tobacco Survey found that 5.9% of U.S. middle and high school students (1.63 million) reported current e-cigarette use — down from 7.7% in 2023 and from a peak of roughly 5 million in 2019 3Ref 3Jamal A, Park-Lee E, Birdsey J, et al. (2024).Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024.2024 prevalence: 5.9% of middle/high school students use e-cigarettes; 7.8% high school, 3.5% middle school. Roughly 7.8% of high school students and 3.5% of middle school students reported current use in 2024 3Ref 3Jamal A, Park-Lee E, Birdsey J, et al. (2024).Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024.2024 prevalence: 5.9% of middle/high school students use e-cigarettes; 7.8% high school, 3.5% middle school.

What actually works: the evidence-supported options

Three categories of intervention have meaningful evidence for adolescent nicotine cessation.

Text-based quit programs. A 2024 randomized clinical trial in JAMA tested "This is Quitting" — a free, automated text messaging program from Truth Initiative designed specifically for teens who vape. Among 1,503 adolescents ages 13–17, those in the intervention group were 35% more likely to report not using nicotine at seven months (abstinence: 37.8% vs. 28.0%; relative risk 1.35) 4Ref 4Graham AL, Cha S, Jacobs MA, Amato MS, Funsten AL, Edwards G, Papandonatos GD (2024).A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users: A Randomized Clinical Trial.35% relative improvement in 7-month abstinence for the This is Quitting text intervention vs. control (37.8% vs. 28.0%); first RCT of a quit-vaping program in teens. This is currently the strongest published trial evidence for an adolescent-specific vaping cessation intervention, and the program remains free and publicly available.

Behavioral counseling and motivational interviewing. Counseling that meets teens where they are — rather than lecturing — is the backbone of every guideline recommendation. Motivational interviewing (MI) is particularly suited to adolescents because it builds internal motivation rather than external pressure. A randomized trial of MI versus brief advice in 162 adolescent smokers found that MI produced greater short-term reductions in daily use 5Ref 5Colby SM, Nargiso J, Tevyaw TO, Barnett NP, Metrik J, Lewander W, Woolard RH, Rohsenow DJ, Monti PM (2012).Enhanced Motivational Interviewing versus Brief Advice for Adolescent Smoking Cessation: Results from a Randomized Clinical Trial.MI produced greater short-term daily cigarette reductions than brief advice in adolescent smokers 14–18; abstinence rates remained low without higher-intensity support. Counseling is consistently listed as a necessary component of any pharmacotherapy for teens, not an add-on 6Ref 6Beis I, Dimou A, Kotoulas SC, Pataka A (2025).Nicotine Replacement Therapy as a Smoking Cessation Tool for Adolescents: An Update.Systematic review of 12 studies: NRT reduces nicotine use frequency in adolescents; behavioral support consistently needed alongside NRT for meaningful outcomes.

Pharmacotherapy for older teens. A 2025 randomized trial in JAMA — the first to test varenicline specifically for vaping cessation in youth — found that varenicline plus brief behavioral counseling produced continuous abstinence rates of 51% in the last month of treatment vs. 14% for placebo, with a 6-month follow-up abstinence rate of 28% vs. 7% in the placebo group 7Ref 7Evins AE, Cather C, Reeder HT, et al. (2025).Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial.Varenicline produced continuous abstinence of 51% vs. 14% (placebo) at end of treatment, and 28% vs. 7% at 6-month follow-up, in youth 16–25 who vaped daily. The trial enrolled youth ages 16–25 who vaped daily or near-daily and did not regularly smoke. Varenicline is not approved for teens under 16 and requires a clinician to prescribe and monitor.

For teens with established dependence who are not ready for varenicline, NRT (patches, gum, lozenges) can reduce withdrawal discomfort. A 2025 systematic review of 12 studies found that NRT produced meaningful reductions in nicotine use frequency, though long-term abstinence rates were modest and behavioral support was consistently needed alongside NRT for best results 6Ref 6Beis I, Dimou A, Kotoulas SC, Pataka A (2025).Nicotine Replacement Therapy as a Smoking Cessation Tool for Adolescents: An Update.Systematic review of 12 studies: NRT reduces nicotine use frequency in adolescents; behavioral support consistently needed alongside NRT for meaningful outcomes. A clinician should guide which form and duration are appropriate for age.

Going cold turkey has the lowest success rate among dependent users. Some occasional or lighter users do manage it, but for teens who vape daily — particularly those who reach for their device first thing in the morning — unassisted quitting rarely sticks.

How parents can help without pushing the teen away

The evidence on adolescent behavior change is consistent: conversations that are curious rather than accusatory, and that center the teen's own goals, land better than ultimatums. A few practical approaches:

• Ask before telling. Ask what the teen likes about vaping, whether they have ever thought about stopping, and what a different relationship with vaping would look like for them. Listen more than you talk.
• Frame it as a health issue, not a moral failure. Nicotine dependence is a real physical condition. Teens who feel judged or controlled tend to dig in; teens who feel supported are more likely to engage with help.
• Set a clear, calm boundary about the home — no vaping indoors — without attaching that boundary to shame or ultimatums that cannot be enforced.
• Offer to make the appointment and come along. This signals partnership, not surveillance. A pediatrician can conduct a structured assessment and have the quit conversation in ways that often land differently coming from a clinician than from a parent.
• Know the free resources. "This is Quitting" (textSTART to 36072) is specifically designed for teens and is free. Smokefree.gov also has patient-facing materials on NRT options 8Ref 8National Cancer Institute / HHS (2023).Using Nicotine Replacement Therapy.Patient-facing resource on NRT options and how to use them; relevant to parent guidance on free quit resources.

When does a clinician need to be involved?

A pediatrician or family medicine clinician is a natural first call for any teen who vapes daily, has tried to quit and relapsed, or shows signs of withdrawal between uses (irritability, difficulty concentrating, anxiety, trouble sleeping). Clinicians can:

• Screen for nicotine dependence using validated tools such as the Hooked on Nicotine Checklist (HONC), a 10-item questionnaire validated specifically for adolescents, where any "yes" answer signals some degree of dependence 9Ref 9DiFranza JR, Savageau JA, Fletcher K, et al. (2004).Measuring the Loss of Autonomy Over Nicotine Use in Adolescents: The DANDY (Development and Assessment of Nicotine Dependence in Youths) Study.Validation of the Hooked on Nicotine Checklist (HONC) for adolescent nicotine dependence screening; high internal consistency and test-retest reliability.
• Screen for co-occurring anxiety, ADHD, or depression — common in adolescent vapers, and treating the underlying condition often makes cessation more achievable.
• Advise on NRT (off-label for adolescents with moderate to severe dependence) or, for teens 16 and older, consider a referral for varenicline with behavioral counseling 7Ref 7Evins AE, Cather C, Reeder HT, et al. (2025).Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial.Varenicline produced continuous abstinence of 51% vs. 14% (placebo) at end of treatment, and 28% vs. 7% at 6-month follow-up, in youth 16–25 who vaped daily.
• Check lung function or pulse oximetry if the teen reports cough, shortness of breath, or chest pain — symptoms that can indicate e-cigarette or vaping product use-associated lung injury (EVALI), which the CDC has documented since the 2019 outbreak 10Ref 10Krishnasamy VP, Hallowell BD, Ko JY, et al. (2020).Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020.2,807 EVALI hospitalizations and 68 deaths documented; at least 15% of cases were under 18; primarily associated with THC-containing products and vitamin E acetate.

If anxiety, depression, or ADHD appears to be driving the use, a behavioral health clinician can address both the nicotine dependence and the underlying condition in the same course of treatment.

What to track before the appointment

Bringing organized information helps the clinician act quickly. Consider noting:

• How many times per day the teen uses their device, and at what times (first thing in the morning is clinically significant)
• The device brand and nicotine strength, if known — a 5% pod delivers far more nicotine than a 1.5% device
• Prior quit attempts: what was tried, how long it lasted, what triggered relapse
• Symptoms between uses: irritability, trouble focusing, anxiety, sleep disruption
• Whether the teen wants to quit or is coming primarily to please a parent — motivation level is the strongest single predictor of success